What is CYP11A1?
This enzyme is also called the cholesterol side-chain cleavage enzyme or P450scc.
It is one of the cytochrome P450 monooxygenases (CYPs) . CYPs eliminate toxins and drugs from the human body. However, some like CYP11A1, are not involved in detoxification but in steroid hormone production.
The activity of this enzyme is age and sex-dependent .
However, it is also active in the brain, skin, lungs, gut, bone, breast, and prostate .
Furthermore, it plays a function in the thymus and immune cells .
This enzyme is involved in steroid hormone production. It is necessary for testis development, pregnancy-related processes, and mating-related behavior .
Some of them show strong anti-tumor activity against breast cancer, liver cancer, glioma (brain cancer), and leukemia .
Decreasing the enzyme prevents allergic diarrhea and inflammation in mice .
People with partial or complete enzyme deficiency have adrenal insufficiency . This is a condition in which the adrenal glands do not produce adequate amounts of steroid hormones.
They also have sexual development disorders .
Lifelong hormone replacement therapy is necessary for this condition. Without therapy the disease is lethal .
The condition is rare. So far, only 19 patients with CYP11A1 complete deficiency-causing mutations have been reported worldwide .
Women with rs2279357 T/T are more prone to develop breast cancer (530 patients and 546 controls) .
A five nucleotide repeat variant in CYP11A1, when repeated four times (TTTTA)4, increases the risk of polycystic ovary syndrome (PCOS) (meta-analysis, 1,236 patients, and 1,306 controls) .
On the other hand, having a (TTTTA)6 variant, with 6 repeats, decreases the risk of polycystic ovary syndrome (PCOS) (meta-analysis, 1,236 patients, and 1,306 controls) .
People with (TTTTA)6 may have an increased risk of metastatic and high-grade prostate cancer (206 subjects) .
Increasing or Decreasing CYP11A1
These increase CYP11A1
- Ginseng (Panax ginseng) 
- UVB and UVC 
- Bisphenol A (BPA) 
- Pemirolast, clobenpropit, desogestrel, dexmedetomidine, and tizanidine 
These decrease CYP11A1:
- Ketoconazole, posaconazole, carbenoxolone, and selegiline